Skip to main content
HairCited
Fig. 5. Summary of evidence for the use of combination treatment of topical minoxidil in male and female androgenetic alopecia (Varothai and Bergfeld, 2014)
Figure 7. Fig. 5. Summary of evidence for the use of combination treatment of topical minoxidil in male and female androgenetic alopecia (Varothai and Bergfeld, 2014)

Description

A summary of clinical evidence supporting combination therapy with topical minoxidil for androgenetic alopecia in both men and women. The data, compiled by Varothai and Bergfeld (2014), indicates that multi-modal treatment approaches may offer improved outcomes compared to monotherapy.

More Figures from This Paper

A clinical photograph demonstrating female pattern hair loss, showing characteristic diffuse thinning across the crown and mid-scalp. FPHL affects women with varying degrees of severity and may lead to significant psychological distress.

Figure 3

A clinical photograph demonstrating female pattern hair loss, showing characteristic diffuse thinning across the crown and mid-scalp. FPHL affects women with varying degrees of severity and may lead to significant psychological distress.

photograph
The Ludwig scale classifies female pattern hair loss into three progressive stages, ranging from minimal thinning at the crown (Grade I) to extensive hair loss across the top of the scalp (Grade III). This grading system remains one of the most widely used clinical tools for assessing FPHL severity.

Figure 4

The Ludwig scale classifies female pattern hair loss into three progressive stages, ranging from minimal thinning at the crown (Grade I) to extensive hair loss across the top of the scalp (Grade III). This grading system remains one of the most widely used clinical tools for assessing FPHL severity.

diagram
Sinclair's classification divides midline pattern alopecia into four intensity levels, progressing from a normal-appearing scalp to increasingly visible widening of the central part. The scale, introduced by Sinclair et al. (2005), provides a practical visual reference for clinicians assessing hair loss severity.

Figure 5

Sinclair's classification divides midline pattern alopecia into four intensity levels, progressing from a normal-appearing scalp to increasingly visible widening of the central part. The scale, introduced by Sinclair et al. (2005), provides a practical visual reference for clinicians assessing hair loss severity.

diagram
Olsen's classification system highlights the characteristic triangular or Christmas-tree pattern of frontovertical alopecia seen in female pattern hair loss. The accentuation of thinning at the frontal midline distinguishes this pattern from the more diffuse Ludwig classification.

Figure 6

Olsen's classification system highlights the characteristic triangular or Christmas-tree pattern of frontovertical alopecia seen in female pattern hair loss. The accentuation of thinning at the frontal midline distinguishes this pattern from the more diffuse Ludwig classification.

diagram

Figure 7

910 × 394px · 363.4 KB

Source Paper

Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.

International journal of women's dermatology (2018)

PMID: 30627618

DOI: 10.1016/j.ijwd.2018.05.001

Cite This Figure

![Figure 7: A summary of clinical evidence supporting combination therapy with topical minoxidil for androgenetic alopecia in both men and women. The data, compiled by Varothai and Bergfeld (2014), indicates that multi-modal treatment approaches may offer improved outcomes compared to monotherapy.](https://pdfs.citedhealth.com/figures/30627618/148.png)

> Source: G Fabbrocini et al. "Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.." *International journal of women's dermatology*, 2018. PMID: [30627618](https://pubmed.ncbi.nlm.nih.gov/30627618/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/30627618/148.png" alt="A summary of clinical evidence supporting combination therapy with topical minoxidil for androgenetic alopecia in both men and women. The data, compiled by Varothai and Bergfeld (2014), indicates that multi-modal treatment approaches may offer improved outcomes compared to monotherapy." />
  <figcaption>Figure 7. A summary of clinical evidence supporting combination therapy with topical minoxidil for androgenetic alopecia in both men and women. The data, compiled by Varothai and Bergfeld (2014), indicates that multi-modal treatment approaches may offer improved outcomes compared to monotherapy.<br>  Source: G Fabbrocini et al. "Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.." <em>International journal of women's dermatology</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30627618/">30627618</a></figcaption>
</figure>

Related Evidence

A
Minoxidil for Androgenetic Alopecia

Grade A · 299 studies

 A
Minoxidil for Female Pattern Hair Loss

Grade A · 111 studies

 A
Finasteride for Androgenetic Alopecia

Grade A · 206 studies

 A
PRP Therapy for Androgenetic Alopecia

Grade A · 144 studies

 A
Spironolactone for Female Pattern Hair Loss

Grade A · 45 studies

 A
Spironolactone for Androgenetic Alopecia

Grade A · 45 studies